首页> 外文期刊>VirusDisease >Anti-viral activity of Zingiber officinale (Ginger) ingredients against the Chikungunya virus
【24h】

Anti-viral activity of Zingiber officinale (Ginger) ingredients against the Chikungunya virus

机译:<斜斜探的抗病毒活性<斜斜探官员(姜)成分对Chikungunya病毒的成分

获取原文
       

摘要

Chikungunya is one of the highly infectious viral disease without vaccine and anti-viral. Aim of present study is to check the anti-chikungunya activities of Zingiber officinale (Ginger) in the animal cell culture model. The medicinal plant extract was prepared from Z. officinale rhizome. Median tissue culture infective dose (TCID _(50)) of Chikungunya virus (CHIKV) and Maximum non-toxic dose (MNTD) of Z. officinale extract was determined in Vero cell-line on the basis of cell viability followed by MTT assay. In vitro?anti-chikungunya activity was performed in Vero cell-line with MNTD and half of MNTD of Z. officinale medicinal plant extract. The anti-viral effect of Z. officinale was studied by observing the cytopathic effects and cell viability measured by MTT assay. Maximum non-toxic dose of? Z. officinale plant extract was found 62.5?μg/ml. During anti-chikungunya experimentation, cell viability increased to 51.05% and 35.10%, when Vero cells were pre-treated with MNTD and half of MNTD of Z. officinale extract respectively. Similarly, in co-treatment, when MNTD, half of MNTD of Z. officinale and Median tissue culture infective dose CHIKV were inoculated simultaneously , then the viability of Vero cell-line was increases by 52.90% and 49.02% respectively. The rhizome extracts of Z. officinale have high potential to treat CHIKV. Medicinal plants and their metabolites are most important sources of antimicrobial and can be utilized for the development of new drugs. In view of the rapid expansion of CHIKV at the global level, there is an urgent need to develop newer anti-chikungunya drugs.
机译:Chikungunya是没有疫苗和抗病毒的高度传染性病毒疾病之一。目前研究的目的是检查动物细胞培养模型中Zingiber Officinale(Ginger)的抗Chikungunya活动。药物植物提取物由Z. Officinale Rhizome制备。基于MTT测定的Chikungunya病毒(Chikv)和Z. Officinale提取物的最大无毒剂量(MNTD)的中位组织培养物(Chikv)和最大无毒剂量(MNTD)的感染剂量(TCID _(50))。体外α抗Chikungunya活性在Vero细胞系中进行,MNTD和Z. Officinale药用植物提取物的一半。通过观察MTT测定测量的细胞病变和细胞活力来研究Z. Officinale的抗病毒作用。最大无毒剂量? Z. Officinale植物提取物发现62.5μg/ ml。在抗Chikungunya实验期间,当分别用MnTD和Z. Officinale提取物的MNTD MNTD的一半进行预处理,细胞活力增加到51.05%和35.10%。类似地,在共同治疗中,当同时接种Z. Officinale和中值组织培养剂量Chikv的MNTD的MNTD中的一半分别增加52.90%和49.02%的vikv。 Z. Officinale的根茎提取物具有高潜力治疗Chikv。药用植物及其代谢物是最重要的抗菌药物来源,可用于开发新药。鉴于全球水平的CHIKV快速扩张,迫切需要开发新的抗Chikungunya药物。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号